Nine months into the COVID-19 pandemic, the bitter conflict about mask wearing continues. In my view, the reason for this is because the science behind the mask mandates is never addressed by the politicians and public health professionals making the recommendations, and the media have completely given up on their journalistic duty. What you end… Read More »
By Michael Le Page , Clare Wilson , Jessica Hamzelou , Sam Wong , Adam Vaughan , Conrad Quilty-Harper and Layal Liverpool A BioNTech laboratory in Mainz, GermanyMarzena Skubatz/laif/Camera Press Latest coronavirus news as of 5 pm on 11 November EU confirms deal to buy up to 300 million doses of Pfizer-BioNTech vaccine candidate The… Read More »
At this point, the Food and Drug Administration could grant emergency-use authorization. In other words, the two vaccines could hinge on the combined results of 64 people. Haseltine concludes: If — or perhaps when — positive early results from these trials are announced, keep my warnings in mind. These protocols seem designed to get a… Read More »
Researchers from 68 sites across the country, led by David E. Leaf and Shruti Gupta from the Division of Renal Medicine at Harvard-affiliated Brigham and Women’s Hospital, have investigated the effects of the anti-inflammatory drug tocilizumab on critically ill patients with laboratory-confirmed COVID-19. Unlike steroids, which suppress the immune system more broadly, tocilizumab specifically inhibits the receptor for… Read More »